Artigos com autorizações de acesso público - Mindie H. NguyenSaiba mais
39 artigos não disponíveis publicamente
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
YC Hsu, DQ Huang, MH Nguyen
Nature reviews Gastroenterology & hepatology 20 (8), 524-537, 2023
Autorizações: US National Institutes of Health
Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021
J Li, A Ha, F Rui, B Zou, H Yang, Q Xue, X Hu, Y Xu, L Henry, M Barakat, ...
Alimentary pharmacology & therapeutics 56 (3), 396-406, 2022
Autorizações: US National Institutes of Health
Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B
J Li, HI Yang, ML Yeh, MH Le, AK Le, YH Yeo, CY Dai, S Barnett, ...
The Journal of infectious diseases 224 (2), 294-302, 2021
Autorizações: National Natural Science Foundation of China
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
K Liu, J Choi, A Le, TCF Yip, VWS Wong, SL Chan, HLY Chan, ...
Alimentary pharmacology & therapeutics 50 (9), 1037-1048, 2019
Autorizações: US National Institutes of Health
Incidences and determinants of functional cure during entecavir or tenofovir disoproxil fumarate for chronic hepatitis B
YC Hsu, ML Yeh, GLH Wong, CH Chen, CY Peng, M Buti, M Enomoto, ...
The Journal of infectious diseases 224 (11), 1890-1899, 2021
Autorizações: US National Institutes of Health
Pleiotropic effects of statins: untapped potential for statin pharmacotherapy
S Mohammad, H Nguyen, M Nguyen, M Abdel-Rasoul, V Nguyen, ...
Current vascular pharmacology 17 (3), 239-261, 2019
Autorizações: US National Institutes of Health
Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B
CY Chang, N Aziz, M Poongkunran, A Javaid, HN Trinh, DT Lau, ...
Journal of clinical gastroenterology 52 (3), 255-261, 2018
Autorizações: US National Institutes of Health
Lower observed hepatocellular carcinoma incidence in chronic hepatitis B patients treated with entecavir: results of the ENUMERATE study
J Ahn, JK Lim, HM Lee, AS Lok, M Nguyen, CQ Pan, A Mannalithara, H Te, ...
Official journal of the American College of Gastroenterology| ACG 111 (9 …, 2016
Autorizações: US National Institutes of Health
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
DQ Huang, A Tran, ML Yeh, S Yasuda, PC Tsai, CF Huang, CY Dai, ...
Hepatology 78 (5), 1558-1568, 2023
Autorizações: US National Institutes of Health, National Medical Research Council, Singapore
Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
M Okada, M Enomoto, N Kawada, MH Nguyen
Expert review of gastroenterology & hepatology 11 (12), 1095-1104, 2017
Autorizações: US National Institutes of Health
Factors associated with multimorbidity patterns in older adults in England: findings from the English Longitudinal Study of Aging (ELSA)
H Nguyen, KC Chua, A Dregan, S Vitoratou, I Bayes-Marin, B Olaya, ...
Journal of aging and health 32 (9), 1120-1132, 2020
Autorizações: UK Medical Research Council, European Commission
Substantial gaps in evaluation and treatment of patients with hepatitis B in the US
Q Ye, LY Kam, YH Yeo, N Dang, DQ Huang, R Cheung, MH Nguyen
Journal of hepatology 76 (1), 63-74, 2022
Autorizações: US National Institutes of Health
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection
Y Feng, H Wu, DQ Huang, C Xu, H Zheng, M Maeda, X Zhao, L Wang, ...
European Radiology 30, 6357-6368, 2020
Autorizações: National Natural Science Foundation of China
Increasing comorbidities in a South Korea insured population‐based cohort of patients with chronic hepatitis B
H Oh, DW Jun, IH Lee, HJ Ahn, BO Kim, S Jung, MH Nguyen
Alimentary Pharmacology & Therapeutics 52 (2), 371-381, 2020
Autorizações: US National Institutes of Health
Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: a practice implication
E Ogawa, H Toyoda, E Iio, DW Jun, CF Huang, M Enomoto, YC Hsu, ...
Clinical Infectious Diseases 71 (11), 2840-2848, 2020
Autorizações: US National Institutes of Health
Current gaps and opportunities in HBV prevention, testing and linkage to care in the United States—a call for action
YH Yeo, MH Nguyen
Alimentary Pharmacology & Therapeutics 53 (1), 63-78, 2021
Autorizações: US National Institutes of Health
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
M Liu, TC Tseng, DW Jun, ML Yeh, H Trinh, GLH Wong, CH Chen, ...
Hepatology international 15, 71-81, 2021
Autorizações: US National Institutes of Health
Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics
YC Hsu, MT Wei, MH Nguyen
Expert Review of Gastroenterology & Hepatology 11 (11), 999-1008, 2017
Autorizações: US National Institutes of Health
Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patients
RJ Wong, J Wantuck, A Valenzuela, A Ahmed, C Bonham, A Gallo, ...
Digestive diseases and sciences 59, 183-191, 2014
Autorizações: US National Institutes of Health
Early multiplexed detection of cirrhosis using giant magnetoresistive biosensors with protein biomarkers
E Ng, AK Le, MH Nguyen, SX Wang
ACS sensors 5 (10), 3049-3057, 2020
Autorizações: US National Science Foundation
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador